These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22802229)

  • 1. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
    Jackson EK; Kochanek SJ; Gillespie DG
    Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
    Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats.
    Jackson EK; Zhang M; Liu W; Mi Z
    J Pharmacol Exp Ther; 2007 Nov; 323(2):431-7. PubMed ID: 17726157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
    Jackson EK; Mi Z
    Hypertension; 2008 Jun; 51(6):1637-42. PubMed ID: 18443229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells.
    Cheng D; Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F770-80. PubMed ID: 23303411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 Inhibition, NPY
    Jackson EK; Gillespie DG; Tofovic SP
    J Pharmacol Exp Ther; 2020 Apr; 373(1):135-148. PubMed ID: 32015161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    Giannocco G; Oliveira KC; Crajoinas RO; Venturini G; Salles TA; Fonseca-Alaniz MH; Maciel RM; Girardi AC
    Eur J Pharmacol; 2013 Jan; 698(1-3):74-86. PubMed ID: 23051671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDF-1α (Stromal Cell-Derived Factor 1α) Induces Cardiac Fibroblasts, Renal Microvascular Smooth Muscle Cells, and Glomerular Mesangial Cells to Proliferate, Cause Hypertrophy, and Produce Collagen.
    Jackson EK; Zhang Y; Gillespie DD; Zhu X; Cheng D; Jackson TC
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29114002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
    Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.
    Mentlein R; Dahms P; Grandt D; Krüger R
    Regul Pept; 1993 Dec; 49(2):133-44. PubMed ID: 7907802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.
    Jackson EK; Mi E; Ritov VB; Gillespie DG
    Hypertension; 2018 Oct; 72(4):909-917. PubMed ID: 30354710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.
    Liu L; Liu J; Tian XY; Wong WT; Lau CW; Xu A; Xu G; Ng CF; Yao X; Gao Y; Huang Y
    Antioxid Redox Signal; 2014 Oct; 21(11):1571-81. PubMed ID: 24328731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.
    Samikannu B; Chen C; Lingwal N; Padmasekar M; Engel FB; Linn T
    PLoS One; 2013; 8(12):e82639. PubMed ID: 24349326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease.
    McCormick LM; Kydd AC; Read PA; Ring LS; Bond SJ; Hoole SP; Dutka DP
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):274-81. PubMed ID: 24503784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsu MI; Chen YJ
    Int J Cardiol; 2013 Oct; 168(6):5390-5. PubMed ID: 24012160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
    Marney A; Kunchakarra S; Byrne L; Brown NJ
    Hypertension; 2010 Oct; 56(4):728-33. PubMed ID: 20679179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
    Dimitrijević M; Stanojević S; Vujić V; Kovacević-Jovanović V; Beck-Sickinger A; Demuth H; von Hörsten S
    J Neuroimmunol; 2002 Aug; 129(1-2):35-42. PubMed ID: 12161018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.